Anti-Anxiety

By  

Current Bioactive Compounds, Vol. 1, Iss. 1, 2005-04 ,pp. : 59-59

Bentham Science Publishers

Access to resources Recommend Favorite

Would CCK-4 challenges be useful to predict anti-anxiety effects of non anti-panic drugs?

By Boulenger J.P.   Jerabek I.   Cocirc teacute G.   Lavalleacute e Y.J.   Jolicoeur F.B.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 374-375

Elsevier

Access to resources Recommend Favorite

Antianxiety activity of Gelsemium sempervirens

By Dutt Vandana   Dhar V. J.   Sharma Anupam  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 48, Iss. 10, 2010-10 ,pp. : 1091-1096

Informa Healthcare

Access to resources Recommend Favorite

Alprazolam and handling-habituation antianxiety action in rats: effects of the type of handling exposure and drug doses

By Saacute nchez R.   Fernaacute ndez-Teruel A.   Escorihuela R.M.   Tobentilde a A.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 375-376

Elsevier

Access to resources Recommend Favorite

Cholecystokinin in anxiety

By van Megen H.J.G.M.   Westenberg H.G.M.   den Boer J.A.   Kahn R.S.  

European Neuropsychopharmacology, Vol. 6, Iss. 4, 1996-11 ,pp. : 263-280

Elsevier

Access to resources Recommend Favorite